Replay available

USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call

USANA Health Sciences, Inc. (NYSE: USNA) Q4 2025 earnings conference call, held 2026-02-18. Replay captured from the company's public earnings webcast.

Wed, February 18, 2026 at 11:00 AMendedReplay
USANA Health Sciences, Inc. (USNA) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Andrew Masuda

Director of Investor Relations

Kevin Guest

Chairman and Chief Executive Officer

Doug Hecking

Chief Financial Officer

Walter Note

Chief Operating Officer

Brett Neidig

Chief Commercial Officer

Anthony Levzinski

Analyst, Sidonia Company

Ivan Feintzis

Analyst, Tigers Financial

Catherine Armstrong

Chief Science Officer

Replay transcript excerpt

Greetings. Welcome to USANA Health Sciences' fourth quarter and fiscal year 2025 earnings call. At this time, all participants will be in listen-only mode. The question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero from your telephone keypad. Please note this conference is being recorded. At this time, I'll now turn the conference over to Andrew Masuda, Director of Investor Relations. Thank you, Andrew. You may now begin. Thanks, Robin. Good morning, everyone. We appreciate you joining us to review our fourth quarter and fiscal year 2025 results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.usana.com. Shortly following the call, a replay will be available on our website. As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events, or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ, perhaps materially, from the results projected in such forward-looking statements. Examples of these statements include those regarding our strategies and outlook for fiscal year 2026, uncertainty related to the economic and operating environment around the world, and our operations and financial results. We caution you that these statements should be considered in conjunction with disclosures, including specific risk factors and financial data contained in our most recent filings with the SEC. I'm joined by our Chairman and Chief Executive Officer, Kevin Guest, our Chief Financial Officer, Doug Hecking, our Chief Commercial Officer, Brett Neidig, our Chief Operatin...

More from Usana Health Sciences, Inc.